Frédéric Baribaud
Johnson & Johnson, USA
Biography
Frédéric Baribaud holds a PhD from the University of Lausanne and has conducted his Post-doctoral studies at the University of Pennsylvania. He has worked at Incyte Corporation in a discovery role on target validation and as a Compound Team Co-Lead for small molecular inhibitors. For the past ten years, he has been working at Janssen R&D in Imunology Biomarkers on various inflammatory diseases. In his current role as Scientific Director he is focusing on obtaining disease rational for targets and patient segmentation for inflammatory bowel diseases.
Abstract
Abstract : Molecular surrogates of histologic activity in crohn’s disease